Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Pegylated Liposomal Doxorubicin
Sponsor: Merck Sharp & Dohme LLC